[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100559095":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":23,"locations":28,"responsibleParty":48,"collaborators":51,"id":58,"slug":18,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":18,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":18,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":76,"overallStatus":81,"whyStopped":18,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Preterm babies","All the newborns will be studied to identify babies who will develop later (at 36 weeks of postcomptional age) Chronic Lung Disease of prematurity",[12],"Other: Blood sampling",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":18},"Blood sampling","\\- Collection and analysis of blood samples",[9],null,[20],{"name":21,"affiliation":5,"role":22},"Giovanni Vento","PRINCIPAL_INVESTIGATOR",[24],{"name":21,"role":25,"phone":26,"phoneExt":18,"email":27},"CONTACT","+390630153237","giovanni.vento@unicatt.it",[29],{"facility":30,"status":18,"city":31,"state":32,"zip":33,"country":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS UOC Neonatologia","Rome","RM","00168","Italy",{"type":36,"coordinates":37},"Point",[38,39],12.51133,41.89193,{"lat":39,"lon":38},[42,44,45],{"name":21,"role":25,"phone":43,"phoneExt":18,"email":27},"+39 0630153237",{"name":21,"role":22,"phone":18,"phoneExt":18,"email":18},{"name":46,"role":47,"phone":18,"phoneExt":18,"email":18},"Marco De Santis","SUB_INVESTIGATOR",{"type":22,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"VENTO GIOVANNI","Chief UOC of Neonatology",[52,54,56],{"name":53,"class":6},"Azienda Ospedaliera Universitaria Policlinico \"G. Martino\"",{"name":55,"class":6},"Azienda Ospedaliero-Universitaria di Parma",{"name":57,"class":6},"Ospedali Riuniti di Foggia","100559095",false,"NCT06559670","Prevention of Chronic Lung Disease (CLD - Prevention Study)","Prevention of Chronic Lung Disease: New High Risk Profile for Early Detection and Management Starting From Perinatal Life (CLD - Prevention Study)","Inclusion Criteria:\n\nInfants with gestational age \\\u003C 32 weeks with at least one of the following signs of acute respiratory failure within the first 24 hours of life:\n\n* need for mechanical ventilation;\n* need for noninvasive respiratory support;\n* need for oxygen administration;\n* need for surfactant administration\n\nExclusion Criteria:\n\n* Congenital malformations\n* Neuromuscular diseases.","ALL","1 Hour","24 Hours",{"count":68,"type":69},42,"ESTIMATED","INTERVENTIONAL",[72],"NA","Primary endpoint:\n\n\\- prospectively identify potential biomarkers able to predict the severe course of pulmonary funcion in the first 12 months of life and realize a new profile to early identify hugh risk newborns\n\nSecondary endpoints:\n\n* detect genetic variance causation model (by MiSeq Illumina platform) correlating with severe pulmonary dysfunction and asthma development;\n* detect MIcroRNAs as well as anti- and pro-inflammatory cytokine variations (MIP-1α, MCP-1, IL-8, TNF-α, IFN-ɣ, IL-10) correlating with the severity of pulmonary dysfunction in the first 12 months of life and the risk of asthma development\n\nPopulation: preterm infants with gestational age \\\u003C 32 weeks who have suffered from acute respiratory insufficiency at birth\n\nIntervention:\n\n* Assessment of prenatal risk factors.\n* Collection of the following biological specimens: 1) a vaginal swab from the mothers of enrolled infants 2) a placenta sample 3) an arterial or venous cord blood sample at birth 4) peripheral blood samples from enrolled infants: the first within 48 hours of life, the subsequent ones at 7 and 28 days of life and at 6 and 12 months of age 5) bronchoalveolar lavage (BALF) samples exclusively in infants intubated for clinical reasons within the first 24 hours of life, at 7 and 28 days of life. 6) first meconium sample issued and subsequent stool samples at 7 and 28 days of life and at 6 and 12 months of age, of enrolled infants\n* Respiratory Functionality Testing at 6 and 12 months of age",[75],"Chronic Lung Disease",[75,77,78,79,80],"Newborns","COPD","Preterm infants","Bronchopulmonary dysplasia","NOT_YET_RECRUITING","2024-08-14",{"date":84,"type":85},"2024-08-19","ACTUAL",{"date":87,"type":69},"2024-09",{"date":89,"type":69},"2026-09",{"name":5,"class":6},1]